Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey.
The Covid-19 pandemic required many clinical trials to adopt a decentralized framework to continue research activities during lock down restrictions. The STOPCoV study was designed to assess the safety and efficacy of Covid-19 vaccines in those aged 70 and above compared to those aged 30-50 years of...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-05-01
|
| Series: | PLOS Digital Health |
| Online Access: | https://doi.org/10.1371/journal.pdig.0000242 |